Neutrophil–lymphocyte ratio reflects tumour‐infiltrating lymphocytes and tumour‐associated macrophages and independently predicts poor outcome in breast cancers with neoadjuvant chemotherapy (Englisch)
- Neue Suche nach: Li, Joshua J X
- Neue Suche nach: Ni, Shelly Y B
- Neue Suche nach: Tsang, Julia Y S
- Neue Suche nach: Chan, Wai Yin
- Neue Suche nach: Hung, Ray K W
- Neue Suche nach: Lui, Joshua W H
- Neue Suche nach: Ng, Sally W Y
- Neue Suche nach: Shum, Leong Kwong
- Neue Suche nach: Tang, Ying Fei
- Neue Suche nach: Tse, Gary M
- Neue Suche nach: Li, Joshua J X
- Neue Suche nach: Ni, Shelly Y B
- Neue Suche nach: Tsang, Julia Y S
- Neue Suche nach: Chan, Wai Yin
- Neue Suche nach: Hung, Ray K W
- Neue Suche nach: Lui, Joshua W H
- Neue Suche nach: Ng, Sally W Y
- Neue Suche nach: Shum, Leong Kwong
- Neue Suche nach: Tang, Ying Fei
- Neue Suche nach: Tse, Gary M
In:
Histopathology
;
84
, 5
;
810-821
;
2024
- Aufsatz (Zeitschrift) / Elektronische Ressource
-
Titel:Neutrophil–lymphocyte ratio reflects tumour‐infiltrating lymphocytes and tumour‐associated macrophages and independently predicts poor outcome in breast cancers with neoadjuvant chemotherapy
-
Beteiligte:Li, Joshua J X ( Autor:in ) / Ni, Shelly Y B ( Autor:in ) / Tsang, Julia Y S ( Autor:in ) / Chan, Wai Yin ( Autor:in ) / Hung, Ray K W ( Autor:in ) / Lui, Joshua W H ( Autor:in ) / Ng, Sally W Y ( Autor:in ) / Shum, Leong Kwong ( Autor:in ) / Tang, Ying Fei ( Autor:in ) / Tse, Gary M ( Autor:in )
-
Erschienen in:Histopathology ; 84, 5 ; 810-821
-
Verlag:
-
Erscheinungsdatum:01.04.2024
-
Format / Umfang:821 pages
-
ISSN:
-
DOI:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Elektronische Ressource
-
Sprache:Englisch
-
Schlagwörter:
-
Datenquelle:
Inhaltsverzeichnis – Band 84, Ausgabe 5
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 721
-
Issue Information| 2024
- 723
-
Tumour 63 protein (p63) in breast pathology: biology, immunohistochemistry, diagnostic applications, and pitfallsAlkhayyat, Rabab / Abbas, Areeg / Quinn, Cecily M / Rakha, Emad A et al. | 2024
- 742
-
PD‐L1 expression in vulvar cancer: a systematic review and meta‐analysisBaandrup, Louise / Sand, Freja Lærke / Aalborg, Gitte Lerche / Nøttrup, Trine J / Fiehn, Anne‐Marie K / Kjaer, Susanne K et al. | 2024
- 753
-
Primary mucinous adenocarcinoma of the urethra: A clinicopathological analysis of 35 casesGe, Rongbin / Zhang, Jing / Lu, Min / Shi, Yuchuan / Yan, Shi / Xue, Zixuan / Wang, Zongwei / Lopez‐Beltran, Antonio / Cheng, Liang et al. | 2024
- 765
-
Histologic manifestations of ocrelizumab‐associated intestinal and hepatic injury in patients with multiple sclerosisChalla, Bindu / Esnakula, Ashwini Kumar et al. | 2024
- 776
-
Spindle cell rhabdomyosarcomas: With TFCP2 rearrangements, and novel EWSR1::ZBTB41 and PLOD2::RBM6 gene fusions. A study of five cases and review of the literatureBradová, Martina / Mosaieby, Elaheh / Michal, Michael / Vaněček, Tomáš / Ing, Stanislav Kormunda / Grossmann, Petr / Koshyk, Olena / Kinkor, Zdeněk / Laciok, Šimon / Nemcová, Antónia et al. | 2024
- 794
-
Abdominal inflammatory myofibroblastic tumour: Clinicopathological and molecular analysis of 20 cases, highlighting potential therapeutic targetsVernemmen, Astrid I P / Samarska, Iryna V / Speel, Ernst‐Jan M / Riedl, Robert G / Goudkade, Danny / de Bruïne, Adriaan P / Wouda, Siep / van Marion, Arienne M / Verlinden, Ivana V / van Lijnschoten, Ineke et al. | 2024
- 810
-
Neutrophil–lymphocyte ratio reflects tumour‐infiltrating lymphocytes and tumour‐associated macrophages and independently predicts poor outcome in breast cancers with neoadjuvant chemotherapyLi, Joshua J X / Ni, Shelly Y B / Tsang, Julia Y S / Chan, Wai Yin / Hung, Ray K W / Lui, Joshua W H / Ng, Sally W Y / Shum, Leong Kwong / Tang, Ying Fei / Tse, Gary M et al. | 2024
- 822
-
TRPS1 is a promising marker for all subtypes of breast cancerLui, Joshua W / Tsang, Julia Y / Li, Joshua / Ko, Chun‐Wai / Tam, Fiona / Loong, Thomson C‐W / Tse, Gary M et al. | 2024
- 837
-
Demographics and additional haematologic cancers of patients with histiocytic/dendritic cell neoplasmsKemps, Paul G / Kester, Lennart / Scheijde‐Vermeulen, Marijn A / van Noesel, Carel J M / Verdijk, Robert M / Diepstra, Arjan / van Marion, Ariënne M W / Dors, Natasja / van den Bos, Cor / Bruggink, Annette H et al. | 2024
- 847
-
Digital pathology for reporting histopathology samples, including cancer screening samples – definitive evidence from a multisite studyAzam, Ayesha S / Tsang, Yee‐Wah / Thirlwall, Jenny / Kimani, Peter K / Sah, Shatrughan / Gopalakrishnan, Kishore / Boyd, Clinton / Loughrey, Maurice B / Kelly, Paul J / Boyle, David P et al. | 2024
- 863
-
Associations of TACSTD2/TROP2 and NECTIN‐4/NECTIN‐4 with molecular subtypes, PD‐L1 expression, and FGFR3 mutational status in two advanced urothelial bladder cancer cohortsBahlinger, Veronika / Branz, Annalena / Strissel, Pamela L / Strick, Reiner / Lange, Fabienne / Geppert, Carol I / Klümper, Niklas / Hölzel, Michael / Wach, Sven / Taubert, Helge et al. | 2024
- 877
-
BRAFV600E immunohistochemistry can reliably substitute BRAF molecular testing in the Lynch syndrome screening algorithm in colorectal cancerGrillo, Federica / Paudice, Michele / Pigozzi, Simona / Dono, Maria / Lastraioli, Sonia / Lugaresi, Marialuisa / Bozzano, Silvia / Tognoni, Camilla / Ali, Murad / Sciallero, Stefania et al. | 2024
- 888
-
Markedly increased duodenal villous surface apoptosis in patients taking pre‐exposure prophylaxis (PrEP) against human immunodeficiency virusHutchings, Danielle A / Larson, Brent K / Guindi, Maha / Waters, Kevin M et al. | 2024
- 893
-
Utility of combining OLIG2 and SOX10 IHC expression in CNS tumours: promising biomarkers for subtyping paediatric‐ and adult‐type gliomasAboubakr, Oumaima / Métais, Alice / Maillard, Julien / Hasty, Lauren / Brigot, Enola / Berthaud, Charlotte / Lacombe, Joelle / Pucelle, Noémie / Raynal, Jade / Appay, Romain et al. | 2024
- 900
-
ALK‐rearranged CD30‐positive poorly differentiated lung adenocarcinoma, mimicking anaplastic large‐cell lymphomaGeorge, Giby V / Wallace, Danielle S / Wang, Ying / Carney, John / Elsadawi, Murad / Burack, W Richard / Evans, Andrew G / Barr, Paul M / Velez, Moises J / El Hussein, Siba et al. | 2024
- 903
-
Smooth muscle and adenoma‐like renal tumour (SMART): another example suggesting distinction from mixed epithelial and stromal tumourCollins, Katrina / Kocemba, Joshua / Saad, Mohammed / Acosta, Andres M / Ulbright, Thomas M / Argani, Pedram / Williamson, Sean R et al. | 2024
- 905
-
Metastatic clear cell papillary renal cell ‘tumour’Gupta, Sounak / Dasari, Surendra / Sharma, Vidit / Atwell, Thomas D / Sivasankaran, Gopinath / Smoley, Stephanie A / Hardcastle, Jayson J / Lohse, Christine M / Tekin, Burak / Jimenez, Rafael E et al. | 2024
- 909
-
Aggressive prostate myxoid mesenchymal neoplasm with novel CRTC1::NCOA2 fusionTay, Wan Jing / Jeyasekharan, Anand / Goh, Jian Yuan / Chang, Kenneth Tou En / Kesavan, Arshvin / Lee, Victor K et al. | 2024